On Oct 14th, my Pomalyst chemo treatment came to end after 48 cycles (Cycle 48) or 192 weeks. It feels odd that it is over. It is unfortunate that Pomalyst didn’t remain effective against my multiple myeloma, even when Ninlaro was added back in January. Chemo unfortunately, doesn’t always work out. But, I’m not one to dwell on the past. I’m happy for the year and a half of low and stable cancer levels and I feel positive about my future.
I’m about to start a third week of a new IV chemo called Kyprolis. Perhaps also due to the high amounts of myeloma (cancer) in my blood, my ability to concentrate is limited, and I experience ongoing fatigue and low energy.
I remain hopeful that this new treatment will result in lower and stable cancer levels for a long time. I’m focused on a calm lifestyle, with healthy eating and lots of rest.
Photo: Bedroom at Sunset
On Sunday Oct 14th, I completed Cycle 48. I have Multiple Myeloma and anemia, a rare cancer of the immune system. Multiple myeloma affects the plasma cells, a type of immune cell that produces antibodies to fight infection. These plasma cells are found in the bone marrow. As a blood cancer, it is incurable, but treatable.
From Feb 9th 2015 – October 14th 2018, I was on Pomalyst. I was also on dexamethasone chemo treatment until July 16th 2017, when my dexamethasone treatment ended, due to right eye damage, as reported by my Glaucoma Specialist, from long-term use. From Jan 9th – Oct 14th 2018, I was also on Ninlaro chemo due to rising cancer levels. From July 23rd – Sept 16th, dexamethasone was added to my Ninlaro and Pomalyst chemo treatment, due to excessively high cancer levels.